Schaper Benz & Wise Investment Counsel’s Thermo Fisher Scientific TMO Stock Holding History

Schaper Benz & Wise Investment Counsel’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-376	Closed	-$233K	–	152
2024 Q3	$233K	Hold	376	–	–	0.02%	142
2024 Q2	$208K	Hold	376	–	–	0.02%	142
2024 Q1	$219K	Sell	376 -15	-4%	-$8.42K	0.02%	140
2023 Q4	$208K	Buy	+391	New	+$189K	0.02%	131
2023 Q3	–	Sell	-391	Closed	-$204K	–	137
2023 Q2	$204K	Hold	391	–	–	0.02%	134
2023 Q1	$225K	Hold	391	–	–	0.02%	131
2022 Q4	$215K	Sell	391 -135	-26%	-$71.5K	0.02%	130
2022 Q3	$267K	Sell	526 -15	-3%	-$8.39K	0.03%	122
2022 Q2	$294K	Buy	541 +48	+10%	+$26.4K	0.03%	124
2022 Q1	$291K	Sell	493 -15	-3%	-$8.62K	0.03%	133
2021 Q4	$339K	Hold	508	–	–	0.03%	125
2021 Q3	$290K	Sell	508 -30	-6%	-$16.5K	0.03%	113
2021 Q2	$271K	Hold	538	–	–	0.02%	114
2021 Q1	$246K	Hold	538	–	–	0.02%	114
2020 Q4	$251K	Buy	+538	New	+$252K	0.03%	116

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Schaper Benz & Wise Investment Counsel's TMO Position: Q4 2024 in Review

Schaper Benz & Wise Investment Counsel sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 376 shares — an estimated $233K sold.

Schaper Benz & Wise Investment Counsel first reported a position in TMO in Q4 2020 and held it in 15 quarters. The position peaked at $339K in Q4 2021. 2,617 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

Schaper Benz & Wise Investment Counsel reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
Schaper Benz & Wise Investment Counsel sold 376 Thermo Fisher Scientific shares in Q4 2024, an estimated $233K.
Schaper Benz & Wise Investment Counsel first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 15 quarters.
Schaper Benz & Wise Investment Counsel's Thermo Fisher Scientific position peaked at $339K in Q4 2021.
2,617 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Schaper Benz & Wise Investment Counsel's 13F filing for Q4 2024, filed 7 Feb 2025.